Share buybacks · 2021–2025
AstraZeneca share buybacks
$521M+543.2% · FY2025
AstraZeneca (AZN) reported $521M in share buybacks for fiscal 2025, +543.2% year on year.
Share buybacks — Share buybacks are the cash a company spent during the year repurchasing its own stock, taken from the financing section of the cash-flow statement. Most companies buy back nothing at all — the line is absent rather than zero — so this ranking covers the minority that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2021–2025 compound annual growth +36.7%
Figures are reported under IFRS, in US dollars.
Share buybacks at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=AstraZeneca share buybacks |url=https://companiesranked.com/en/company/astrazeneca/share-buybacks |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). AstraZeneca share buybacks. CompaniesRanked. https://companiesranked.com/en/company/astrazeneca/share-buybacksBibTeX
@misc{companiesranked-en-company-astrazeneca-share-buybacks-2026,
author = {{CompaniesRanked}},
title = {{AstraZeneca share buybacks}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/astrazeneca/share-buybacks}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001104659-26-019130 · February 24, 2026
{{cite web |title=AstraZeneca share buybacks — 20-F (0001104659-26-019130) |url=https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/azn-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.